Aspire Private Capital’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-6
Closed -$1K 615
2022
Q2
$1K Hold
6
﹤0.01% 528
2022
Q1
$2K Hold
6
﹤0.01% 486
2021
Q4
$2K Hold
6
﹤0.01% 507
2021
Q3
$3K Hold
6
﹤0.01% 436
2021
Q2
$3K Buy
+6
New +$3K ﹤0.01% 445